Effects of pentoxifylline, 7-nitroindazole, and imipramine on tumor necrosis factor-α and indoleamine 2,3-dioxygenase enzyme activity in the hippocampus and frontal cortex of chronic mild-stress-exposed rats

Neuropsychiatric Disease and Treatment

Volumn 9, Issue , 2013, Pages 697-708

  Mohamed, Bassim ^a,d   Aboul Fotouh, Sawsan ^b,c   Ibrahim, Eman A ^b   Shehata, Hanan ^b   Mansour, Amal A ^b   Az Yassin, Nemat ^a   El Eraky, Wafaa ^a   Abdel Twab, Ahmed M ^b,c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Department of Pharmacology ^*  (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Chronic mild stress; Immunohistochemistry; Kynurenine; nNOS; Serotonin; TNF

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; 7 NITROINDAZOLE; IMIPRAMINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRATE; NITRITE; PENTOXIFYLLINE; SEROTONIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BODY WEIGHT; CHRONIC STRESS; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME ACTIVITY; FRONTAL CORTEX; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MEDIAN RAPHE NUCLEUS; MENTAL STRESS; NEUROCHEMISTRY; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT;

EID: 84878181000     PISSN: 11766328     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S41020     Document Type: Article

References (63)

1. Miura H, Ozaki N, Sawada M, Isobe K, Ohta T, Nagatsu T. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress. 2008;11:198-209.
2. Furtado CP, Maller JJ, Fitzgerald PB. A magnetic resonance imaging study of the entorhinal cortex in treatment-resistant depression. Psychiatry Res. 2008;163:133-142.
3. Rimol LM, Hatberg CB, Nesvåg R, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry. 2010;68:41-50.
4. Myint AM, Kim YK, Verkerk R, Scharpé S, Steinbusch H, Leonard B. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord. 2007;98:143-151.
5. Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D. Neopterin production, tryptophan degradation, and mental depression -what is the link? Brain Behav Immun. 2002;16:590-595.
6. Guillemin GJ, Smythe G, Takikawa O, Brew BJ. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia. 2005;49:15-23.
7. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses. 2003; 61:519-525.
8. Popov A, Abdullah Z, Wickenhauser C, et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest. 2006;116:3160-3170.
9. Fujigaki H, Saito K, Fujigaki S, et al. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem. 2006;139:655-662.
10. Capuron L, Gumnick JF, Musselman DL, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643-652.
11. O'Connor JC, Lawson MA, André C, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry. 2008;14:511-522.
12. Henry CJ, Huang Y, Wynne A, et al. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation. 2008;13:5-15.
13. Oliveira RM, Guimarães FS, Deakin JF. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res. 2008;41:333-341.
14. Yildiz F, Erden BF, Ulak G, Utkan T, Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacol (Berl). 2000;149:41-44.
15. Tonelli LH, Stiller J, Rujescu D, et al. Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand. 2008;117:198-206.
16. Simen BB, Duman CH, Simen AA, Duman RS. TNFα signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry. 2006;59:775-785.
17. McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr. 2008;13: 501-510.
18. Nierenberg AA, Leon AC, Price LH, Shelton RC, Trivedi MH. Crisis of confidence: antidepressant risk versus benefit. J Clin Psychiatry. 2011;72:e11.
19. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl). 1997;134:319-329.
20. Kubera M, Maes M, Holan V, Basta-Kaim A, Roman A, Shani J. Prolonged desipramine treatment increases the production of interleukin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J Affect Disord. 2001;63: 171-178.
21. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioral-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005;52:90-110.
22. Kim SH, Han J, Seog DH, et al. Antidepressant effect of chaihu-shugan-san extract and its constituents in rat models of depression. Life Sci. 2005;76:1297-1306.
23. Cavas M, Navarro JF. Effects of selective neuronal nitric oxide synthase inhibition on sleep and wakefulness in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:56-67.
24. Yagmurlu A, Boleken ME, Ertoy D, Ozsan M, Gokcora IH, Dindar H. Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis. Urology. 2003;61:1037-1041.
25. Bekris S, Antoniou K, Daskas S, Papadopoulou-Daifoti Z. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains. Behav Brain Res. 2005;161:45-59.
26. D'Aquila P, Monleon S, Borsini F, Brain P, Willner P. Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant. Eur J Pharmacol. 1997;340:121-132.
27. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 2nd ed. San Diego: Academic Press; 1986.
28. Wang R, Tang A. Simultaneous determination of kynurenine and tryptophan in serum by high performance liquid chromatography. Se Pu. 2006;24:140-143. Chinese.
29. Bellac CL, Coimbra RS, Christen S, Leib SL. Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Neurobiol Dis. 2006;24:395-402.
30. Mefford IN. Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain. J Neurosci Methods. 1981;3:207-224.
31. Mefford IN, Chang P, Klein DC, Namboodiri MA, Sugden D, Barchas J. Reciprocal day/night relationship between serotonin oxidation and N-acetylation products in the rat pineal gland. Endocrinology. 1983;113: 1582-1586.
32. Hsu S, Raine L. Protein, avidin and biotin in immunohistochemistry. J Histochem Cytochem. 1981;29:1349-1353.
33. Grippo AJ, Francis J, Beltz TG, Felder RB, Johnson AK. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav. 2005;84:697-706.
34. Zhou QG, Zhu LJ, Chen C, et al. Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. J Neurosci. 2011; 25(31):7579-7590.
35. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;1(67):446-457.
36. Ito Y, Saito K, Maruta K, et al. Kynurenine concentration of serum was increased by exercise. Adv Exp Med Biol. 1999;467:717-722.
37. Bah TM, Kaloustian S, Rousseau G, Godbout R. Pretreatment with pentoxifylline has antidepressant-like effects in a rat model of acute myocardial infarction. Behav Pharmacol. 2011;22:779-784.
38. Joca SR, Guimarães FS. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology (Berl). 2006;185:298-305.
39. Zhou QG, Hu Y, Hua Y, et al. Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. J Neurochem. 2007;103:1843-1854.
40. Ulak G, Mutlu O, Akar FY, Komsuoǧlu FI, Tanyeri P, Erden BF. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats. Pharmacol Biochem Behav. 2008;90: 563-568.
41. Wegener G, Volke V, Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol. 2000;130:575-580.
42. Przedborski S, Jackson-Lewis V, Yokoyama R, Shibata T, Dawson VL, Dawson TM. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A. 1996;93:4565-4571.
43. López AS, Alegre E, Díaz A, Mugueta C, González A. Bimodal effect of nitric oxide in the enzymatic activity of indoleamine 2,3-dioxygenase in human monocytic cells. Immunol Lett. 2006;106:163-171.
44. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357:593-615.
45. Walker G, Pfeilschifter J, Kunz D. Mechanisms of suppression of inducible nitric-oxide synthase (iNOS) expression in interferon (IFN)-gamma-stimulated RAW 264.7 cells by dexamethasone. Evidence for glucocorticoid-induced degradation of iNOS protein by calpain as a key step in post-transcriptional regulation. J Biol Chem. 1997;272: 16679-16687.
46. Smith RS. The macrophage theory of depression. Med Hypotheses. 1991;35:298-306.
47. Zhu CB, Blakely RD, Hewlett WA. The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology. 2006;31:2121-2131.
48. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:637-638.
49. Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development. Current Med Chem. 2011;18:245-255.
50. Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev. 2010;6:205-212.
51. Seguin JA, Brennan J, Mangano E, Hayley S. Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatr Dis Treat. 2009;5:5-14.
52. Li S, Wang C, Wang W, Dong H, Hou P, Tang Y. Chronic mild stress impairs cognition in mice: from brain homeostasis to behaviour. Life Sci. 2008;82:934-942.
53. Anisman H, Merali Z, Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegeneration disorders. Prog Neurobiol. 2008;85:1-74.
54. Chen Y, Boettger MK, Reif A, Schmitt A, Uçeyler N, Sommer C. Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain. 2010;6:13.
55. Sharma HS. A combination of tumor necrosis factor-alpha and neuronal nitric oxide synthase antibodies applied topically over the traumatized spinal cord enhances neuroprotection and functional recovery in the rat. Ann N Y Acad Sci. 2010;1199:175-185.
56. Schwartz D, Engelhard D, Gallily R, Matoth I, Brenner T. Glial cells production of inflammatory mediators induced by Streptococcus pneumoniae: inhibition by pentoxifylline, low-molecular-weight heparin and dexamethasone. J Neurol Sci. 1998;155:13-22.
57. Beshay E, Croze F, Prud'homme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol. 2001;98: 272-279.
58. Abbas G, Naqvi S, Dar A. Comparison of monoamine reuptake inhibitors for the immobility time and serotonin levels in the hippocampus and plasma of sub-chronically forced swim stressed rats. Pak J Pharm Sci. 2012;25:441-445.
59. Hsu LC, Ko YJ, Cheng HY, et al. Antidepressant-like activity of the ethanolic extract from Uncaria lanosa Wallich var. appendiculata Ridsd in the forced swimming test and in the tail suspension test in mice. Evid Based Complement Alternat Med. 2012;2012:497302.
60. Kubera M, Symbirtsev A, Basta-Kaim A, et al. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol J Pharmacol. 1996;48:503-506.
61. Kubera M, Kenis G, Bosmans E, et al. Suppressive effect of TRH and imipramine on human interferon-gamma and interleukin-10 production in vitro. Pol J Pharmacol. 2000;2:481-486.
62. Hwang J, Zheng LT, Ock J, et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology. 2008;55:826-834.
63. Zhang J, Huang X, Ye M, et al. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1 A receptor in modulating anxiety-related behavior. J Neurosci. 2010;30:2433-2441.